Save 10% off on your first order with coupon code: PANDA10

Health & Wellness Blog

6Feb, 2026

Foods to Avoid on Wegovy: High-Fat, Trigger Foods & Complete Meal Plan

February 6, 2026|

Wegovy is an approved injectable weight loss medication containing active ingredient semaglutide, a GLP 1 receptor agonist that helps control appetite, regulate blood sugar and promote significant weight loss. In STEP 1 clinical trial, adults using Wegovy pen lost an average of about 15% of their starting body weight over 68 weeks when combined with [...]

6Feb, 2026

Does Mounjaro Cause Body Aches: <1% Direct + 5-10% From Dehydration - Management Guide

February 6, 2026|

Mounjaro body aches affect fewer than 1 in 100 patients directly (uncommon myalgia), while 5-10% experience muscle pain from GI-induced dehydration and electrolyte loss during rapid weight loss. According to the SURMOUNT clinical trials, body aches are not among the primary side effects of Mounjaro (tirzepatide), yet patient reports consistently link these symptoms to magnesium [...]

5Feb, 2026

Zepbound vs Mounjaro: IDENTICAL Tirzepatide – Weight Loss vs Diabetes Branding

February 5, 2026|

If you're confused about whether to ask your healthcare provider for Zepbound or Mounjaro, here's the bottom line: they are the same drug with different brand names and FDA approvals. Both medications contain tirzepatide, a revolutionary dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps people lose weight by reducing appetite [...]

5Feb, 2026

Rybelsus vs Wegovy: Pill vs Pen – Wegovy 15% Loss vs Rybelsus 6 lbs

February 5, 2026|

Same semaglutide molecule, very different results. Wegovy’s once-weekly injection delivers approximately 15% body weight loss in clinical studies, while Rybelsus’s daily pill produces a more modest average of about 6 lbs over 26 weeks at its currently approved doses. The difference comes down to delivery: oral semaglutide has roughly 1% bioavailability through the stomach, whereas [...]

5Feb, 2026

Januvia vs Ozempic: Ozempic (15% Weight Loss), Januvia (2-4lbs) A1c Comparison

February 5, 2026|

When comparing Januvia vs Ozempic, the differences are significant: Ozempic (semaglutide) crushes Januvia (sitagliptin) for weight loss achieving up to 15% body weight reduction compared to Januvia's modest 2 to 4 pounds but Januvia remains substantially cheaper and causes virtually no gastrointestinal side effects. Clinical trials demonstrate Ozempic's superior A1c reduction (1.5-1.8%) compared to Januvia [...]

5Feb, 2026

Medicare Ozempic Coverage 2026: Type 2 Diabetes (Yes), Weight Loss (No) – Complete Guide

February 5, 2026|

Medicare covers Ozempic (semaglutide) for the treatment of type 2 diabetes under Part D prescription drug plans. However, Medicare does not cover Ozempic when prescribed solely for weight loss due to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 which explicitly excludes coverage for weight loss medications. Ozempic is approved for improving blood [...]

20Feb, 2026

Trulicity Coupon 2026: $25 Savings Card, Copay, Discounts Guide

February 20, 2026|

As of early 2026, the average retail price of Trulicity without insurance is approximately $1,395.75 for four Trulicity pens a standard 30-day supply. The good news: several savings programs exist to help eligible patients dramatically reduce what they pay out [...]

17Feb, 2026

Zepbound Insurance Coverage: Complete Guide to Prior Authorization & Approval

February 17, 2026|

Zepbound insurance coverage stands at approximately 45% for commercial plans requiring BMI ≥30 or ≥27 with comorbidities, while Medicare excludes weight-loss indications entirely. Employer-sponsored plans show 55% approval rates after prior authorization. Roughly 97 million Americans are in plans that [...]

13Feb, 2026

Mounjaro Dosage: Complete 2.5mg→15mg Titration Chart + Missed Dose Protocol

February 13, 2026|

Mounjaro (tirzepatide) is an FDA-approved once-weekly injectable medicine manufactured by Eli Lilly for adults and children aged 10 years and older with type 2 diabetes. The active ingredient tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) [...]

6Feb, 2026

Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery

February 6, 2026|

Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and [...]

5Feb, 2026

Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs – Diabetes vs Obesity Drugs

February 5, 2026|

Wegovy delivers approximately 15% body weight loss in clinical trials-dramatically outperforming Trulicity’s average weight reduction of about 7–10 lbs (3–5% of body weight). Both are GLP-1 receptor agonists administered as once-weekly injections, yet Wegovy produces roughly 2.5 times greater weight [...]

1Sep, 2025

Ozempic vs Insulin

September 1, 2025|

Effective blood glucose management is a critical need for many. Ozempic and insulin are two commonly used diabetes medications. While both address diabetes, they function differently. Ozempic is a prescription medication for adults with type 2 diabetes. Interestingly, it also [...]

4Aug, 2025

Is Compounded Mounjaro Safe? Understanding Tirzepatide Compounding for Informed Choices

August 4, 2025|

Tirzepatide is a prescription drug that has been gaining popularity. Millions are exploring it for weight management and diabetes. But sometimes, the exact medication isn't readily available. This leads to "compounding."  What are Compounded Drugs? Compounded versions of medications are [...]

3Jun, 2025

Does Ozempic Cause Hair Loss?

June 3, 2025|

You've scrolled through social media, seen the news, and maybe even heard friends talking about Ozempic and its remarkable weight loss results. It's become a household name, but with its growing popularity comes a wave of questions, especially regarding potential [...]

Go to Top
X